Psychedelic experiential pharmacology: Pioneering clinical explorations with Salvador Roquet
- Citation data:
International Journal of Transpersonal Studies, ISSN: 1942-3241, Vol: 33, Issue: 2, Page: 160-174
- Publication Year:
- Repository URL:
- Arts and Humanities; Psychology; Salvador Roquet; Richard Yensen; R. D. Laing; Carlos Castaneda; psychedelic psychotherapy; psychosynthesis; LSD; ketamine; MDA; ayahuasca; Datura; morning glory seeds; psilocybin; Philosophy; Psychiatry and Psychology; Religion
Richard Yensen was a research fellow at the Maryland Psychiatric Research Center from 1972 to 1976. He studied psychedelic psychotherapy with Stanislav Grof, M.D. and other senior staff. During this time he treated patients with substance abuse disorders, cancer, neurosis, and other health professionals seeking a training experience. Dr. Yensen did his Ph.D. dissertation on the use of MDA in psychotherapy with neurotic outpatients and conducted his research at the MPRC. Through many years of experience in government-sanctioned psychedelic research, he has evolved a non-drug shamanistic psychotherapy called Perceptual Affective Therapy. In the 1990's Richard was co-holder of IND 3250, an investigational new drug permit issued by the U.S. Food and Drug Administration to study LSD and psychotherapy until 2006. He is currently a licensed psychologist in California and director of the Orenda Institute in Vancouver and Cortes Island, British Columbia, Canada and president of the Salvador Roquet Psychosynthesis Association. He has served on the faculties of Harvard Medical School, Johns Hopkins University and the University of Maryland Medical School in Baltimore.